---
title: "Lilly-backed Absci banks $100m to progress endometriosis, hair loss therapy"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290949104.md"
description: "A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser."
datetime: "2026-06-26T09:27:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290949104.md)
  - [en](https://longbridge.com/en/news/290949104.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290949104.md)
generator: "portal-rs"
---

# Lilly-backed Absci banks $100m to progress endometriosis, hair loss therapy

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

### Related Stocks

- [ABSI.US](https://longbridge.com/en/quote/ABSI.US.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)

## Related News & Research

- [Absci (ABSI) Could Be 32% Undervalued Following ABS 201 Data And Earnings](https://longbridge.com/en/news/295686913.md)
- [AbSci: Buy Rating Reaffirmed as ABS-201 Hair-Loss Program Advances; $11 Price Target Maintained](https://longbridge.com/en/news/295652271.md)
- [Netflix parts ways with a key ad exec in a leadership shake-up. Read the leaked memo from its ad chief.](https://longbridge.com/en/news/296834043.md)
- [Kynexis pockets €97m to advance cognition-focused schizophrenia drug](https://longbridge.com/en/news/296501085.md)
- [BioMarin spends up to $490m for Alesta’s bone disease candidate](https://longbridge.com/en/news/296381315.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**